Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-04-10 | 2017-05-10 | 6263 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-06-14 | 2017-06-22 | 12745 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2018-09-07 | 2018-11-22 | 60200 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-01-25 | 2019-05-16 | 73514 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-06-19 | 2019-07-06 | 87077 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96874 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2020-02-27 | 2020-03-27 | 107296 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211086 |
| CANDESARTAN | 4MG | TABLET | Actual shortage | 2024-04-09 | 2024-04-10 | 224727 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |